Related Experiment Video

Updated: Mar 19, 2026

Mutagenesis and Analysis of Genetic Mutations in the GC-rich KISS1 Receptor Sequence Identified in Humans with Reproductive Disorders
12:49

Mutagenesis and Analysis of Genetic Mutations in the GC-rich KISS1 Receptor Sequence Identified in Humans with Reproductive Disorders

Published on: September 4, 2011

14.5K

Beta amino acid-modified and fluorescently labelled kisspeptin analogues with potent KISS1R activity

M A Camerino1, M Liu1, S Moriya2

  • 1Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, 3052, Australia.

Journal of Peptide Science : an Official Publication of the European Peptide Society
|June 11, 2016
PubMed

Keywords:
KISS1R agonistbeta amino acidsfluorescent peptideskisspeptin

More Related Videos

Hypothalamic Kisspeptin Neurons as a Target for Whole-Cell Patch-Clamp Recordings09:39

Hypothalamic Kisspeptin Neurons as a Target for Whole-Cell Patch-Clamp Recordings

Published on: March 17, 2023

3.1K
Author Spotlight: Automated Infusion and Blood Sampling for Precise Hormonal Analysis in Conscious Mice08:56

Author Spotlight: Automated Infusion and Blood Sampling for Precise Hormonal Analysis in Conscious Mice

Published on: August 25, 2023

2.7K

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.2K